Global and China Insulin Market’s Future Lies in Long-acting Insulin, Expected to Reach US$32.24 Billion by 2019

Transparency Market Research Report Added “Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin)” to its database.

Global and China Insulin Market:Overview

The research report states that the global and China insulin market is expected to grow at a CAGR of 6.10% between 2013 and 2019 to reach US$32.2 bn by the end of 2019, from US$19.9 bn in 2012. The global and China insulin market is segmented on the basis of mode of action and source. The modes of action seen in the insulin market are rapid-acting, long-acting, short-acting, intermediate-acting, and premixed. On the other hand, the sources of insulin are human insulin and modern insulin.

Amongst the types of insulin, the long-lasting insulin segment is expected to grow at a CAGR of 8.70% in the forecast period. This mode of action for managing sugar levels will be popular amongst insulin-dependent diabetics, as only a small dosage is required to bring down blood glucose. Additionally, relatively relaxed regulations regarding the pricing of long-lasting insulin and availability of a wide range of products will also foster the growth of this segment in the overall insulin market.

In 2012, the rapid-acting insulin segment was at the second position in the overall market. In the same period, the premixed insulin segment held a market share of over 50% in the global and China insulin market. In the foreseeable future, intermediate-acting and short-acting insulin are expected to lose ground, as diabetics are shifting preferences and neither of these types of insulin are supported by adequate research and development channels.

Browse Market Research Report:
http://www.transparencymarketresearch.com/insulin-market.html

Diabetes is a chronic metabolic disorder wherein the body is either unable to produce insulin (glucose digesting hormone) or unable to utilize the produced insulin to metabolize blood glucose. This condition results in increased blood glucose level, which leads to various chronic and life-threatening diseases. Insulin is a hormone secreted by β-cells of pancreas in order to metabolize the blood sugar. The insulin market is a rapidly growing market. Demand for premixed and long-acting insulin derivatives is growing rapidly due to rising incidences of type 1 diabetes. This report focuses on identifying the current scenario as well as the future market potential for insulin globally. Additionally, the insulin market in China is also analyzed and studied thoroughly. The insulin market is segmented based on two important parameters: by mode of action and by source. By mode of action, the market (global and China) is categorized as rapid-acting, short-acting, intermediate-acting, long-acting and premixed insulin derivatives. Furthermore, by source, the market is categorized as human insulin and modern insulin.

Long-acting insulin derivatives is projected to be the fastest growing segment, expanding at a CAGR of 8.7% during the forecast period from 2013 to 2019. According to the World Health Organization (WHO), more than 366 million people worldwide were diagnosed with diabetes in 2011 and an additional 280 million are expected to be diagnosed over the next 20 years. Majority of these patients are likely to be from emerging markets such as China and India.

Rising demand for long-acting insulin derivatives is attributed to advantages such as reduced number of doses compared to other derivatives. Moreover, strong pipeline, lack of stringent regulations on price capping and high entry barriers for biosimilar manufacturers are other important growth drivers in the market. The market for modern insulin is also expected to increase during the forecast period from 2013 to 2019 due to various factors such as ease-of-administration and higher efficacy.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=259

Global and China insulin market is segmented on the basis of geography as follows:

  • North America

  • Europe

  • Asia Pacific

  • Rest of the World (RoW)

This report gives you access to decisive data such as:

  • Market growth drivers

  • Factors limiting market growth

  • Current market trends

  • Market structure

  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth

  • Up-to-date analyses of market trends and technological improvements

  • Pin-point analyses of market competition dynamics to offer you a competitive edge

  • An analysis of strategies of major competitors

  • An array of graphics and SWOT analysis of major industry segments

  • Detailed analyses of industry trends

  • A well-defined technological growth map with an impact-analysis

  • Offers a clear understanding of the competitive landscape and key product segments

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s